The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin

Journal of the American Society of Nephrology

Volumn 24, Issue 8, 2013, Pages 1250-1261

  Birk, Alexander V ^a   Liu, Shaoyi ^a   Soong, Yi ^a   Mills, William ^a   Singh, Pradeep ^a   Warren, J David ^a   Seshan, Surya V ^a   Pardee, Joel D ^b   Szeto, Hazel H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Neural Essence   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM; CARDIOLIPIN; CYTOCHROME C PEROXIDASE; HEME; HYDROGEN PEROXIDE; MEMBRANE AFFECTING AGENT; SS 31; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CATALYSIS; CELL POLARITY; CONTROLLED STUDY; ENZYME ACTIVITY; KIDNEY DYSFUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; MITOCHONDRION; MITOCHONDRION SWELLING; NONHUMAN; PEROXIDATION; PRIORITY JOURNAL; RAT;

EID: 84881090284     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012121216     Document Type: Article

References (61)

1. Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M, Godinez-Luna T, Svenson LW, Rosenal T: Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: A population-based study. Crit Care 9: R700-R709, 2005
2. Bon D, Chatauret N, Giraud S, Thuillier R, Favreau F, Hauet T: New strategies to optimize kidney recovery and preservation in transplantation. Nat Rev Nephrol 8: 339-347, 2012
3. Chapman JR, O'Connell PJ, Nankivell BJ: Chronic renal allograft dysfunction. J Am Soc Nephrol 16: 3015-3026, 2005
4. Atkinson SJ, Hosford MA, Molitoris BA: Mechanism of actin polymerization in cellular ATP depletion. J Biol Chem 279: 5194-5199, 2004
5. Sharfuddin AA, Molitoris BA: Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 7: 189-200, 2011
6. Puri PS, Varley KG, Kim SW, Barwinsky J, Cohen M, Dhalla NS: Alterations in energy metabolism and ultrastructure upon reperfusion of the ischemic myocardium after coronary occlusion. Am J Cardiol 36: 234- 243, 1975
7. Schmiedl A, Schnabel PA, MallG, GebhardMM, Hunneman DH, Richter J, Bretschneider HJ: The surface to volume ratio of mitochondria, a suitable parameter for evaluating mitochondrial swelling. Correlations during the course of myocardial global ischaemia. Virchows Arch A Pathol Anat Histopathol 416: 305-315, 1990
8. Halestrap AP: A poreway to die: The role ofmitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans 38: 841-860, 2010
9. Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng FY, Zhao Z, Ganger M, Tow CY, Seshan SV: Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury.JAmSocNephrol 22: 1041-1052, 2011
10. Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, Szeto HH: Cellpermeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem279: 34682-34690, 2004
11. Hall AM: Pores for thought: New strategies to re-energize stressed mitochondria in acute kidney injury. J Am Soc Nephrol 22: 986-989, 2011
12. Osman C, Voelker DR, Langer T:Making heads or tails of phospholipids in mitochondria. J Cell Biol 192: 7-16, 2011
13. Frey TG, Mannella CA: The internal structure of mitochondria. Trends Biochem Sci 25: 319-324, 2000
14. Zhang M, Mileykovskaya E, Dowhan W: Gluing the respiratory chain together. Cardiolipin is required for supercomplex formation in the inner mitochondrial membrane. J Biol Chem 277: 43553-43556, 2002
15. Pfeiffer K, Gohil V, Stuart RA, Hunte C, Brandt U, Greenberg ML, Schägger H: Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem 278: 52873-52880, 2003
16. Kiebish MA, Yang K, Sims HF, Jenkins CM, Liu X, Mancuso DJ, Zhao Z, Guan S, Abendschein DR, Han X, Gross RW: Myocardial regulation of lipidomic flux by cardiolipin synthase: Setting the beat for bioenergetic efficiency. J Biol Chem 287: 25086-25097, 2012
17. Claypool SM:Cardiolipin, a critical determinant ofmitochondrial carrier protein assembly and function. Biochim Biophys Acta 1788: 2059- 2068, 2009
18. Lesnefsky EJ, Gudz TI, Migita CT, Ikeda-Saito M, Hassan MO, Turkaly PJ, Hoppel CL: Ischemic injury to mitochondrial electron transport in the aging heart: Damage to the iron-sulfur protein subunit of electron transport complex III. Arch Biochem Biophys 385: 117-128, 2001
19. Lesnefsky EJ, Minkler P, Hoppel CL: Enhanced modification of cardiolipin during ischemia in the aged heart. JMol Cell Cardiol 46: 1008- 1015, 2009
20. Vogel F, Bornhövd C, Neupert W, Reichert AS: Dynamic subcompartmentalization of themitochondrial inner membrane.JCellBiol 175: 237-247, 2006
21. Ott M, Zhivotovsky B, Orrenius S: Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ 14: 1243-1247, 2007
22. Petrosillo G, Ruggiero FM, Pistolese M, Paradies G: Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: Role of cardiolipin. J Biol Chem279: 53103-53108, 2004
23. Petrosillo G, Casanova G, Matera M, Ruggiero FM, Paradies G: Interaction of peroxidized cardiolipin with rat-heart mitochondrial membranes: Induction of permeability transition and cytochrome c release. FEBS Lett 580: 6311-6316, 2006
24. Korytowski W, Basova LV, Pilat A, Kernstock RM, Girotti AW: Permeabilization of the mitochondrial outer membrane by Bax/truncated Bid (tBid) proteins as sensitized by cardiolipin hydroperoxide translocation: Mechanistic implications for the intrinsic pathway of oxidative apoptosis. J Biol Chem 286: 26334-26343, 2011
25. Wiswedel I, Gardemann A, Storch A, Peter D, Schild L: Degradation of phospholipids by oxidative stress-exceptional significance of cardiolipin. Free Radic Res 44: 135-145, 2010
26. Basova LV, Kurnikov IV, Wang L, Ritov VB, Belikova NA, Vlasova II, Pacheco AA, Winnica DE, Peterson J, Bayir H, Waldeck DH, Kagan VE: Cardiolipin switch in mitochondria: Shutting off the reduction of cytochrome c and turning on the peroxidase activity. Biochemistry 46: 3423-3434, 2007
27. Belikova NA, Vladimirov YA, Osipov AN, Kapralov AA, Tyurin VA, Potapovich MV, Basova LV, Peterson J, Kurnikov IV, Kagan VE: Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin- containing membranes. Biochemistry 45: 4998-5009, 2006
28. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova II, Zhao Q, Zou M, Di P, SvistunenkoDA, Kurnikov IV, BorisenkoGG:Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1: 223-232, 2005
29. Zhao K, Luo G, Giannelli S, Szeto HH: Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. BiochemPharmacol 70: 1796-1806, 2005
30. Cohen BE, McAnaney TB, Park ES, Jan YN, Boxer SG, Jan LY: Probing protein electrostatics with a synthetic fluorescent amino acid. Science 296: 1700-1703, 2002
31. Leventis PA, Grinstein S: The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 39: 407-427, 2010
32. Petit JM, Maftah A, Ratinaud MH, Julien R: 10N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem 209: 267-273, 1992
33. Paradies G, Petrosillo G, Paradies V, Ruggiero FM: Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease. Cell Calcium 45: 643-650, 2009
34. Vladimirov YA, Proskurnina EV, Izmailov DY, Novikov AA, Brusnichkin AV, Osipov AN, Kagan VE: Mechanism of activation of cytochrome C peroxidase activity by cardiolipin. Biochemistry (Mosc) 71: 989-997, 2006
35. Sinibaldi F, Howes BD, PiroMC, Polticelli F, Bombelli C, Ferri T, Coletta M, Smulevich G, Santucci R: Extended cardiolipin anchorage to cytochrome c: A model for protein-mitochondrial membrane binding. JBiol Inorg Chem 15: 689-700, 2010
36. Sinibaldi F, Fiorucci L, Patriarca A, Lauceri R, Ferri T, ColettaM, Santucci R: Insights into cytochrome c-cardiolipin interaction. Role played by ionic strength. Biochemistry 47: 6928-6935, 2008
37. Santucci R, Ascoli F: The Soret circular dichroism spectrum as a probe for the heme Fe(III)-Met(80) axial bond in horse cytochrome c. J Inorg Biochem 68: 211-214, 1997
38. Zuk A, Bonventre JV, Brown D, Matlin KS: Polarity, integrin, and extracellularmatrix dynamics in the postischemic rat kidney. AmJ Physiol 275: C711-C731, 1998
39. Schwartz N, Hosford M, Sandoval RM, Wagner MC, Atkinson SJ, Bamburg J, Molitoris BA: Ischemia activates actin depolymerizing factor: Role in proximal tubulemicrovillar actin alterations. AmJ Physiol 276: F544-F551, 1999
40. Cho J, Won K, Wu D, Soong Y, Liu S, Szeto HH, Hong MK: Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron Artery Dis 18: 215-220, 2007
41. Cho S, Szeto HH, Kim E, Kim H, Tolhurst AT, Pinto JT: A novel cellpermeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD J Biol Chem 282: 4634-4642, 2007
42. Thomas DA, Stauffer C, Zhao K, Yang H, Sharma VK, Szeto HH, Suthanthiran M: Mitochondrial targeting with antioxidant peptide SS- 31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function. J Am Soc Nephrol 18: 213-222, 2007
43. Kloner RA, Hale SL, Dai W, Gorman RC, Shuto T, Koomalsingh KJ, Gorman JH 3rd, Sloan RC, Frasier CR, Watson CA, Bostian PA, Kypson AP, Brown DA: Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide. J Am Heart Assoc 1: e001644, 2012
44. Eirin A, Li Z, Zhang X, Krier JD, Woollard JR, Zhu XY, Tang H, Herrmann SM, Lerman A, Textor SC, Lerman LO: A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension 60: 1242-1249, 2012
45. Smith RA, Hartley RC, Cochemé HM, Murphy MP: Mitochondrial pharmacology. Trends Pharmacol Sci 33: 341-352, 2012
46. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ: Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am J Physiol Cell Physiol 294: C460-C466, 2008
47. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW 3rd, Kang L, Rabinovitch PS, Szeto HH, Houmard JA, Cortright RN, Wasserman DH, Neufer PD: Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 119: 573-581, 2009
48. Powers SK, Hudson MB, Nelson WB, Talbert EE, Min K, Szeto HH, Kavazis AN, Smuder AJ: Mitochondria-targeted antioxidants protect against mechanical ventilation-induced diaphragm weakness. Crit Care Med 39: 1749-1759, 2011
49. Borisenko GG, Kapralov AA, Tyurin VA, Maeda A, Stoyanovsky DA, Kagan VE: Molecular design of new inhibitors of peroxidase activity of cytochrome c/cardiolipin complexes: Fluorescent oxadiazolederivatized cardiolipin. Biochemistry 47: 13699-13710, 2008
50. Kagan VE, Bayir A, Bayir H, Stoyanovsky D, Borisenko GG, Tyurina YY, Wipf P, Atkinson J, Greenberger JS, Chapkin RS, Belikova NA: Mitochondria-targeted disruptors and inhibitors of cytochrome c/cardiolipin peroxidase complexes: A new strategy in anti-apoptotic drug discovery. Mol Nutr Food Res 53: 104-114, 2009
51. Atkinson J, Kapralov AA, Yanamala N, Tyurina YY, Amoscato AA, Pearce L, Peterson J, Huang Z, Jiang J, Samhan-Arias AK, Maeda A, Feng W, Wasserloos K, Belikova NA, Tyurin VA, Wang H, Fletcher J, Wang Y, Vlasova II, Klein-Seetharaman J, Stoyanovsky DA, Bayîr H, Pitt BR, Epperly MW, Greenberger JS, Kagan VE: A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death. Nat Commun 2: 497, 2011
52. Ji J, Kline AE, Amoscato A, Samhan-Arias AK, Sparvero LJ, Tyurin VA, Tyurina YY, Fink B, Manole MD, Puccio AM, Okonkwo DO, Cheng JP, Alexander H, Clark RS, Kochanek PM, Wipf P, Kagan VE, Bayir H: Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nat Neurosci 15: 1407-1413, 2012
53. Lesnefsky EJ, Slabe TJ, Stoll MS, Minkler PE, Hoppel CL: Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria.AmJ Physiol Heart Circ Physiol 280: H2770-H2778, 2001
54. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Serena D, Ruggiero FM: Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radic Biol Med 27: 42-50, 1999
55. Lesnefsky EJ, Chen Q, Slabe TJ, Stoll MS, Minkler PE, Hassan MO, Tandler B, Hoppel CL: Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: Role of cardiolipin. Am J Physiol Heart Circ Physiol 287: H258- H267, 2004
56. Kaasik A, Safiulina D, Zharkovsky A, Veksler V: Regulation of mitochondrial matrix volume. Am J Physiol Cell Physiol 292: C157-C163, 2007
57. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, Sammut IA: Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 19: 1088-1095, 2005
58. Plotnikov EY, Chupyrkina AA, Jankauskas SS, Pevzner IB, Silachev DN, Skulachev VP, Zorov DB: Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/ reperfusion. Biochim Biophys Acta 1812: 77-86, 2011
59. Sloan RC, Moukdar F, Frasier CR, Patel HD, Bostian PA, Lust RM, Brown DA: Mitochondrial permeability transition in the diabetic heart: Contributions of thiol redox state and mitochondrial calciumto augmented reperfusion injury. J Mol Cell Cardiol 52: 1009-1018, 2012
60. Nitz M, Mezo AR, Ali MH, Imperiali B: Enantioselective synthesis and application of the highly fluorescent and environment-sensitive amino acid 6-(2-dimethylaminonaphthoyl) alanine (DANA). Chem Commun (Camb) 17: 1912-1913, 2002
61. Chen H-R, Guo X-K, Zhong X-B: Syntheses of aladan and [ald6]ioloatin C and study on their fluorescent properties. Chin J Chem 24: 1411- 1417, 2006